QLQuentin Laurent

Quentin Laurent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Quentin Laurent has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Beyond Symmetric Motifs: Asymmetric Small-Molecule Recognition Directs a New Poly(adenine) Assembly

    by Jessica Bennett, Christophe Lachance-Brais, Saleh Almutairi, Asem Alenaizan, Quentin Laurent, Daniel Saliba, Hanadi F. Sleiman

    DNA/small-molecule hybrid materials provide a powerful route to reprogram nucleic acid structures without covalent modification. However, to date only two small molecules have been shown to direct such assemblies, both relying on symmetric hydrogen-bonding faces. Here, we report that 3-methylxanthine (3MeX), a purine-derived molecule with nonequivalent hydrogen-bonding faces, directs the assembly of poly(deoxyadenylic) acid into a new, cooperative arrangement. Through preorganization experiments, systematic modification of small-molecule binding faces, nucleobase engineering, and molecular dynamics simulations, we characterize key hydrogen-bonding interactions governing this structure. We propose a model in which two poly(deoxyadenylic) acid strands associate in an antiparallel arrangement, held together by hydrogen-bonded quartets, each comprising two adenine bases and two 3MeX molecules, similar to the G-quartets of G-quadruplex structures. The assembly exhibits pronounced thermal hysteresis consistent with a cooperative, nucleation–growth mechanism, and forms from a pharmacologically relevant molecule whereby the recognition process is exquisitely sensitive to small-molecule structure. This work establishes a new interaction motif in DNA/small-molecule hybrids, in which asymmetric, multi-face recognition enables new, directional assemblies of unmodified nucleic acids. We show that this interaction can be integrated into DNA nanotechnology to enable small-molecule-triggered dimerization, and higher-order polymerization of DNA nanostructures. The accessibility of this motif under neutral conditions, together with its tolerance to small-molecule modification, points to potential applications in programmable nanomaterials, and nucleic acid–based systems that interface with biological environments.

  • Impact of Clustered Antigenic Architectures on the Adhesion of Monoclonal Antibodies: Insights from Biomimetic Model Surfaces

    by Océane Ricloux, Chanantida Jongwohan, Galina V. Dubacheva, Liliane Coche-Guérente, Quentin Laurent, Didier Boturyn

    Monoclonal antibodies, thanks to their high affinity and specificity for their antigen targets, are increasingly used as highly selective therapeutics. While antigen expression and clustering at the cell surface critically influence therapeutic activity, quantifying these effects remains challenging due to the lack of well-defined in vitro platforms that enable precise control over antigen spatial organization and density. Surface-based affinity techniques, therefore, provide a powerful approach to address this challenge. For example, the monoclonal antibody rituximab (RTX) recognizes the human cluster of differentiation 20 (CD20) antigen through the formation of tight CD20 dimers and secondary antibody–antibody interactions. We previously reported an optimal inter-CD20 spacing of nearly 2 nm on gold surfaces for efficient interaction with RTX, consistent with concomitant crystallographic studies. However, these studies did not account for the heterogeneous distribution of antigens at the cell surface. Herein, we present well-defined and tunable biomolecular surface assemblies as analytical models of CD20 clusters grafted on self-assembled monolayers via click chemistry, followed by characterization using quartz-crystal microbalance coupled to spectroscopic ellipsometry and surface plasmon resonance. Inspired by biological systems, the present platform represents a simplified and static model that captures selected structural features (e.g., clustering and spacing).This study revealed that CD20 dimerization promotes strong and highly selective binding with RTX, providing a controlled and tunable model for investigating the impact of antigen clustering on antibody binding.

  • Top Cited Papers

    Next-generation materials for nucleic acid delivery

    by Roy van der Meel, Paul A. Wender, Olivia M. Merkel, Irene Lostalé-Seijo, Javier Montenegro, Ali Miserez, Quentin Laurent, Hanadi Sleiman, Paola Luciani


  • Open Access

    Photochemical Stabilization of Self‐Assembled Spherical Nucleic Acids

    by Sepideh Kaviani, Haochen Bai, Trishalina Das, Jathavan Asohan, Abdelrahman Elmanzalawy, Julian Marlyn, Lea El Choueiri, Masad J. Damha, Quentin Laurent, Hanadi F. Sleiman

    Oligonucleotide therapeutics, including antisense oligonucleotides and small interfering RNA, offer promising avenues for modulating the expression of disease‐associated proteins. However, challenges such as nuclease degradation, poor cellular uptake, and unspecific targeting hinder their application. To overcome these obstacles, spherical nucleic acids have emerged as versatile tools for nucleic acid delivery in biomedical applications. Our laboratory has introduced sequence‐defined DNA amphiphiles which self‐assemble in aqueous solutions. Despite their advantages, self‐assembled SNAs can be inherently fragile due to their reliance on non‐covalent interactions and fall apart in biologically relevant conditions, specifically by interaction with serum proteins. Herein, this challenge is addressed by introducing two methods of covalent crosslinking of SNAs via UV irradiation. Thymine photodimerization or disulfide crosslinking at the micellar interface enhance SNA stability against human serum albumin binding. This enhanced stability, particularly for disulfide crosslinked SNAs, leads to increased cellular uptake. Furthermore, this crosslinking results in sustained activity and accessibility for release of the therapeutic nucleic acid, along with improvement in unaided gene silencing. The findings demonstrate the efficient stabilization of SNAs through UV crosslinking, influencing their cellular uptake, therapeutic release, and ultimately, gene silencing activity. These studies offer promising avenues for further optimization and exploration of pre‐clinical, in vivo studies.


  • Sequence-Defined DNA Polymers: New Tools for DNA Nanotechnology and Nucleic Acid Therapy

    by Muhammad Ghufran Rafique, Quentin Laurent, Michael D. Dore, Hassan H. Fakih, Tuan Trinh, Felix J. Rizzuto, Hanadi F. Sleiman

    ConspectusStructural DNA nanotechnology offers a unique self-assembly toolbox to construct soft materials of arbitrary complexity, through bottom-up approaches including DNA origami, brick, wireframe, and tile-based assemblies. This toolbox can be expanded by incorporating interactions orthogonal to DNA base-pairing such as metal coordination, small molecule hydrogen bonding, π-stacking, fluorophilic interactions, or the hydrophobic effect. These interactions allow for hierarchical and long-range organization in DNA supramolecular assemblies through a DNA-minimal approach: the use of fewer unique DNA sequences to make complex structures.Here we describe our research group's work to integrate these orthogonal interactions into DNA and its supramolecular assemblies. Using automated solid phase techniques, we synthesized s equence-defined D NA p olymers (SDPs) featuring a wide range of functional groups, achieving high yields in the process. These SDPs can assemble into not only isotropic spherical morphologies─such as spherical nucleic acids (SNAs)─but also into anisotropic nanostructures such as 1D nanofibers and 2D nanosheets. Our structural and molecular modeling studies revealed new insights into intermolecular chain packing and intramolecular chain folding, influenced by phosphodiester positioning and SDP sequence. Using these new self-assembly paradigms, we created hierarchical, anisotropic assemblies and developed systems exhibiting polymorphism and chiroptical behavior dependent on the SDP sequence. We could also precisely control the size of our nanofiber assemblies via nucleation-growth supramolecular polymerization and create compartmentalized nanostructures capable of precise surface functionalization.The exquisite control over sequence, composition, and length allowed us to combine our SDPs with nanostructures including DNA wireframe assemblies such as prisms, nanotubes, and cubes to create hybrid, stimuli-responsive assemblies exhibiting emergent structural and functional modes. The spatial control of our assemblies enabled their use as nanoreactors for chemical transformations in several ways: via hybridization chain reaction within SNA coronas, through chemical conjugation within SNA cores, and through a molecular "printing" approach within wireframe assemblies for nanoscale information transfer and the creation of anisotropic "DNA-printed" polymer particles.We have also employed our SDP nanostructures toward biological and therapeutic applications. We demonstrated that our SNAs could serve as both extrinsic and intrinsic therapeutic platforms, with improved cellular internalization and biodistribution profiles, and excellent gene silencing activities. Using SDPs incorporating hydrophobic dendrons, high-affinity and highly specific oligonucleotide binding to human serum albumin was demonstrated. These structures showed an increased stability to nuclease degradation, reduced nonspecific cellular uptake, no toxicity even at high concentrations, and excellent biodistribution beyond the liver, resulting in unprecedented gene silencing activity in various tissues.Control over the sequence has thus presented us with a unique polymeric building block in the form of the SDP, which combines the chemical and structural diversity of polymers with the programmability of DNA. By linking these orthogonal assembly languages, we have discovered new self-assembly rules, created DNA-minimal nanostructures, and demonstrated their utility through a range of applications. Developing this work further will open new avenues in the fields of DNA nanomaterials, nucleic acid therapeutics, as well as block copolymer self-assembly.


  • Open Access

    Self‐Assembly and Biological Properties of Highly Fluorinated Oligonucleotide Amphiphiles

    by Quentin Laurent, Beatrice L. Bona, Jathavan Asohan, Marta Rosati, Sinan Faiad, Francesca Baldelli Bombelli, Pierangelo Metrangolo, Hanadi F. Sleiman

    Nucleic acids, used as therapeutics to silence disease‐related genes, offer significant advantages over small molecule drugs: they provide high specificity, the ability to target “undruggable” molecules, and adaptability to a wide range of disease phenotypes. However, their instability in biological media, as well their rapid clearance from the organism limit their applicability, necessitating the use of nanocarriers to overcome these challenges. Among these strategies, spherical nucleic acids (SNA)—composed of a densely packed corona of oligonucleotides around a nanoparticle—have emerged as a powerful tool, in particular when self‐assembled from DNA amphiphiles. This non‐covalent strategy however has caveats, especially when it comes to stability in complex biological media, where these SNAs disassemble in contact to serum proteins. Here, we developed highly fluorinated DNA amphiphiles that readily self‐assemble into SNAs and have tunable stability profiles in biological media. They are made of branched fluorinated moieties with potentially improved biodegradability as compared to their linear counterparts. Depending on the number of fluorophilic interactions, the self‐assembled SNAs can have excellent serum stabilities—up to days—and readily deliver nucleic acid therapeutics for gene silencing applications. These systems show great potential as promising candidates for nucleic acid‐based therapies.


  • Open Access

    Self‐Assembly and Biological Properties of Highly Fluorinated Oligonucleotide Amphiphiles

    by Quentin Laurent, Beatrice L. Bona, Jathavan Asohan, Marta Rosati, Sinan Faiad, Francesca Baldelli Bombelli, Pierangelo Metrangolo, Hanadi F. Sleiman

    Nucleic acids, used as therapeutics to silence disease‐related genes, offer significant advantages over small molecule drugs: they provide high specificity, the ability to target “undruggable” molecules, and adaptability to a wide range of disease phenotypes. However, their instability in biological media, as well their rapid clearance from the organism limit their applicability, necessitating the use of nanocarriers to overcome these challenges. Among these strategies, spherical nucleic acids (SNA)—composed of a densely packed corona of oligonucleotides around a nanoparticle—have emerged as a powerful tool, in particular when self‐assembled from DNA amphiphiles. This non‐covalent strategy however has caveats, especially when it comes to stability in complex biological media, where these SNAs disassemble in contact to serum proteins. Here, we developed highly fluorinated DNA amphiphiles that readily self‐assemble into SNAs and have tunable stability profiles in biological media. They are made of branched fluorinated moieties with potentially improved biodegradability as compared to their linear counterparts. Depending on the number of fluorophilic interactions, the self‐assembled SNAs can have excellent serum stabilities—up to days—and readily deliver nucleic acid therapeutics for gene silencing applications. These systems show great potential as promising candidates for nucleic acid‐based therapies.


  • Open Access

    DNA Hierarchical Superstructures from Micellar Units: Stiff Hydrogels and Anisotropic Nanofibers

    by Michael D. Dore, Quentin Laurent, Christophe Lachance‐Brais, Trishalina Das, Xin Luo, Hanadi F. Sleiman

    Supramolecular materials have been assembled using a wide range of interactions, including the hydrophobic effect, DNA base‐pairing, and hydrogen bonding. Specifically, DNA amphiphiles with a hydrophobic building block self‐assemble into diverse morphologies depending on the length and composition of both blocks. Herein, we take advantage of the orthogonality of different supramolecular interactions – the hydrophobic effect, Watson‐Crick‐Franklin base pairing and RNA kissing loops – to create hierarchical self‐assemblies with controlled morphologies on both the nanometer and the micrometer scales. Assembly through base‐pairing leads to the formation of hybrid, multi‐phasic hydrogels with high stiffness and self‐healing properties. Assembly via hydrophobic core interactions gives anisotropic, discrete assemblies, where DNA fibers with one sequence are terminated with DNA spheres bearing different sequences. This work opens new avenues for the bottom‐up construction of DNA‐based materials, with promising applications in drug delivery, tissue engineering, and the creation of complex DNA structures from a minimum array of components.


  • Open Access

    Impact of the Core Chemistry of Self‐Assembled Spherical Nucleic Acids on their In Vitro Fate

    by Sinan Faiad, Quentin Laurent, Alexander L. Prinzen, Jathavan Asohan, Daniel Saliba, Violeta Toader, Hanadi F. Sleiman

    Nucleic acid therapeutics (NATs), such as mRNA, small interfering RNA or antisense oligonucleotides are extremely efficient tools to modulate gene expression and tackle otherwise undruggable diseases. Spherical nucleic acids (SNAs) can efficiently deliver small NATs to cells while protecting their payload from nucleases, and have improved biodistribution and muted immune activation. Self‐assembled SNAs have emerged as nanostructures made from a single DNA‐polymer conjugate with similar favorable properties as well as small molecule encapsulation. However, because they maintain their structure by non‐covalent interactions, they might suffer from disassembly in biologically relevant conditions, especially with regard to their interaction with serum proteins. Here, we report a systematic study of the factors that govern the fate of self‐assembled SNAs. Varying the core chemistry and using stimuli‐responsive disulfide crosslinking, we show that extracellular stability upon binding with serum proteins is important for recognition by membrane receptors, triggering cellular uptake. At the same time, intracellular dissociation is required for efficient therapeutic release. Disulfide‐crosslinked SNAs combine these two properties and result in efficient and non‐toxic unaided gene silencing therapeutics. We anticipate these investigations will help the translation of promising self‐assembled structures towards in vivo gene silencing applications.


  • Open Access

    Impact of the Core Chemistry of Self‐Assembled Spherical Nucleic Acids on their In Vitro Fate

    by Sinan Faiad, Quentin Laurent, Alexander L. Prinzen, Jathavan Asohan, Daniel Saliba, Violeta Toader, Hanadi F. Sleiman

    Nucleic acid therapeutics (NATs), such as mRNA, small interfering RNA or antisense oligonucleotides are extremely efficient tools to modulate gene expression and tackle otherwise undruggable diseases. Spherical nucleic acids (SNAs) can efficiently deliver small NATs to cells while protecting their payload from nucleases, and have improved biodistribution and muted immune activation. Self‐assembled SNAs have emerged as nanostructures made from a single DNA‐polymer conjugate with similar favorable properties as well as small molecule encapsulation. However, because they maintain their structure by non‐covalent interactions, they might suffer from disassembly in biologically relevant conditions, especially with regard to their interaction with serum proteins. Here, we report a systematic study of the factors that govern the fate of self‐assembled SNAs. Varying the core chemistry and using stimuli‐responsive disulfide crosslinking, we show that extracellular stability upon binding with serum proteins is important for recognition by membrane receptors, triggering cellular uptake. At the same time, intracellular dissociation is required for efficient therapeutic release. Disulfide‐crosslinked SNAs combine these two properties and result in efficient and non‐toxic unaided gene silencing therapeutics. We anticipate these investigations will help the translation of promising self‐assembled structures towards in vivo gene silencing applications.